PARATEK PHARMACEUTICALS

Registrant on federal lobbying filings · filed 2025 to 2026

$0 Income reported

1 Clients represented

7 Filings counted

0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. It also reported $110,000 of in-house lobbying expenses, which is what a registrant files when it lobbies for itself. Everything on this page is grouped by the registrant's LDA id (401109327), not by name.

Clients 1

PARATEK PHARMACEUTICALS $110,000 7 filings

Reported by year 2 years

2026 $40,000 2 filings
2025 $70,000 5 filings

Issues lobbied 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 5

Defense, Dept of (DOD) 6
Health & Human Services, Dept of (HHS) 6
HOUSE OF REPRESENTATIVES 6
SENATE 6
Office of Management & Budget (OMB) 2

Recent filings 7 total

Q2

PARATEK PHARMACEUTICALS

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $20,000 expenses · posted Jun 26, 2026

View → Q1

PARATEK PHARMACEUTICALS

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $20,000 expenses · posted Mar 27, 2026

View → Q4

PARATEK PHARMACEUTICALS

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $20,000 expenses · posted Dec 22, 2025

View → Q3

PARATEK PHARMACEUTICALS

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $20,000 expenses · posted Sep 29, 2025

View → Q2

PARATEK PHARMACEUTICALS

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $20,000 expenses · posted Jun 27, 2025

View → Q1

PARATEK PHARMACEUTICALS

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $10,000 expenses · posted Mar 28, 2025

View → RR

PARATEK PHARMACEUTICALS

1st Quarter (Jan 1 - Mar 31) 2025 · posted Mar 13, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.